Table 6.
Relation between grade of fibrosis and evaluated biomarkers in CHC and HCC groups.
F2 | F3 | F4 | P | |
---|---|---|---|---|
TGF-β1 (pg/ml) | ||||
CHC | 102.3 ± 62.3a | 222.1 ± 69.8b | 308.3 ± 91.3c | 0.012 |
HCC | — | 201.3 ± 89.2a | 299.1 ± 81.6b | 0.011 |
VEGF (pg/ml) | ||||
CHC | 40.2 ± 16.2 | 45.2 ± 10.8 | 41.1 ± 8.9 | 0.451 |
HCC | — | 182.5 ± 69.8 | 215.9 ± 81.5 | 0.097 |
sFas (pg/ml) | ||||
CHC | 302.5 ± 106.1a | 385.2 ± 98.5b | 490.2 ± 106.2b | 0.012 |
HCC | — | 502.3 ± 108.2a | 711.3 ± 102.1b | 0.029 |
miR-122 | ||||
CHC | 2.3 ± 1.41a | 3.0 ± 1.71a | 5.5 ± 1.36b | 0.039 |
HCC | — | 5.62 ± 2.03 | 6.8 ± 2.33 | 0.091 |
miR-21 | ||||
CHC | 3.8 ± 1.88a | 4.6 ± 2.53a | 7.9 ± 2.00b | 0.027 |
HCC | — | 6.15 ± 2.88a | 9.8 ± 3.11b | 0.034 |
Values are expressed as means ± SE; mean values within a row not sharing common superscript letters (a, b, c) were significantly different; P < 0.05.